Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer

Overview of attention for article published in BMC Cancer, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 16,475 followers.

RT @gomezalvaro: Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer | BMC Cancer |…

15 Apr 2022

Reply Repost Favourite

RT @gomezalvaro: Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer | BMC Cancer |…

14 Apr 2022

Reply Repost Favourite

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer | BMC Cancer | Full Text https://t.co/KtJ37ZR8RM

14 Apr 2022

Reply Repost Favourite

#BestStudyoftheDay: Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer https://t.co/MDUhepXkd0 – BMC Cancer - #senology #breast #cancer #oncology

14 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.